InflaRx (IFRX) Stock Chart & Stock Price History → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free IFRX Stock Alerts $1.46 +0.02 (+1.39%) (As of 05/28/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends InflaRx Stock Price Performance5 Day Performance+1.39%1 Month Performance+5.04%3 Month Performance-17.98%6 Month Performance+16.80%Year-To-Date Performance-10.43%1 Year Performance-64.90% Receive IFRX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for InflaRx and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Crypto 101 MediaTech GIANT’s Plans to Revolutionize Crypto…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. IFRX Stock Chart for Wednesday, May, 29, 2024 IFRX Chart by TradingView InflaRx Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/28/2024$1.44$1.46+1.39%$1.49$1.40191,852 shs$85.97 million05/27/2024$1.44$1.44$1.51$1.43209,700 shs$84.79 million05/24/2024$1.48$1.44-2.70%$1.51$1.43209,753 shs$84.79 million05/23/2024$1.63$1.48-9.20%$1.63$1.45263,020 shs$87.14 million05/22/2024$1.52$1.63+7.24%$1.72$1.54388,048 shs$95.97 million05/21/2024$1.54$1.52-1.30%$1.56$1.47250,293 shs$89.50 million Get the Latest News and Ratings for IFRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for InflaRx and its competitors with MarketBeat's FREE daily newsletter. 05/20/2024$1.63$1.54-5.52%$1.68$1.52158,298 shs$90.68 million05/17/2024$1.45$1.63+12.41%$1.65$1.42483,773 shs$95.97 million05/16/2024$1.40$1.45+3.57%$1.49$1.4052,356 shs$85.38 million05/15/2024$1.43$1.40-2.10%$1.48$1.3582,515 shs$82.43 million05/14/2024$1.25$1.43+14.40%$1.47$1.30299,475 shs$84.20 million05/13/2024$1.18$1.25+5.93%$1.35$1.19143,803 shs$73.60 million05/10/2024$1.20$1.18-1.67%$1.25$1.17226,428 shs$69.48 million05/09/2024$1.20$1.20$1.30$1.18306,652 shs$70.66 million05/08/2024$1.24$1.20-3.23%$1.29$1.17264,912 shs$70.66 million05/07/2024$1.30$1.24-4.25%$1.32$1.21187,159 shs$73.01 million05/06/2024$1.38$1.30-6.16%$1.41$1.28236,410 shs$76.25 million05/03/2024$1.38$1.38$1.45$1.28179,353 shs$81.25 million05/02/2024$1.41$1.38-2.13%$1.43$1.30143,015 shs$81.25 million05/01/2024$1.37$1.41+2.92%$1.43$1.33184,265 shs$83.02 million04/30/2024$1.39$1.37-1.44%$1.44$1.3437,668 shs$80.67 million04/29/2024$1.33$1.39+4.51%$1.45$1.32170,346 shs$81.84 million04/26/2024$1.39$1.33-4.32%$1.43$1.28169,301 shs$78.31 million04/25/2024$1.36$1.39+2.21%$1.41$1.26146,063 shs$81.85 million04/24/2024$1.36$1.36$1.43$1.3371,453 shs$80.08 million04/23/2024$1.37$1.36-0.73%$1.46$1.3297,199 shs$80.08 million04/22/2024$1.35$1.37+1.48%$1.41$1.31115,749 shs$80.67 million04/19/2024$1.26$1.35+7.14%$1.38$1.27136,141 shs$79.49 million04/18/2024$1.27$1.26-0.40%$1.42$1.25120,599 shs$74.19 million04/17/2024$1.31$1.27-3.44%$1.34$1.24274,068 shs$74.48 million04/16/2024$1.39$1.31-5.76%$1.41$1.25178,127 shs$77.13 million04/15/2024$1.50$1.39-7.33%$1.50$1.37145,859 shs$81.84 million04/12/2024$1.54$1.50-2.60%$1.55$1.45223,615 shs$88.32 million04/11/2024$1.52$1.54+1.32%$1.65$1.51114,727 shs$90.68 million04/10/2024$1.62$1.52-6.17%$1.66$1.51932,330 shs$89.50 million04/09/2024$1.52$1.62+6.58%$1.66$1.46453,358 shs$95.39 million04/08/2024$1.55$1.52-1.94%$1.64$1.5180,452 shs$89.50 million04/05/2024$1.56$1.55-0.64%$1.68$1.50365,160 shs$91.26 million04/04/2024$1.55$1.56+0.65%$1.60$1.50140,064 shs$91.85 million04/03/2024$1.54$1.55+0.65%$1.66$1.52220,672 shs$91.26 millionThe #1 Crypto That You Don’t Own… Yet (Ad)There’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay attention to above all others: Venture capital firms. You want to follow venture capital money into cryptocurrencies before anyone gets word of what’s happening.Click here for all the details…04/02/2024$1.52$1.54+1.32%$1.58$1.5156,341 shs$90.68 million04/01/2024$1.54$1.52-1.30%$1.59$1.5149,940 shs$67.95 million03/29/2024$1.54$1.54$1.57$1.51317,780 shs$68.84 million03/28/2024$1.54$1.54$1.57$1.51317,779 shs$68.84 million03/27/2024$1.54$1.54$1.60$1.52190,094 shs$68.84 million03/26/2024$1.54$1.54$1.60$1.5295,978 shs$68.84 million03/25/2024$1.49$1.54+3.36%$1.61$1.50147,155 shs$68.84 million03/22/2024$1.54$1.49-3.25%$1.59$1.49396,522 shs$66.60 million03/21/2024$1.69$1.54-8.88%$1.70$1.40624,665 shs$68.84 million03/20/2024$1.69$1.69$1.75$1.64239,499 shs$75.54 million03/19/2024$1.50$1.69+12.67%$1.82$1.54254,597 shs$75.54 million03/18/2024$1.58$1.50-5.06%$1.57$1.50149,419 shs$67.05 million03/15/2024$1.52$1.58+3.95%$1.62$1.49123,809 shs$70.63 million03/14/2024$1.58$1.52-3.80%$1.57$1.4891,755 shs$67.94 million03/13/2024$1.57$1.58+0.64%$1.62$1.5667,055 shs$70.63 million03/12/2024$1.62$1.57-3.09%$1.69$1.56120,561 shs$70.19 million03/11/2024$1.62$1.62$1.72$1.57170,802 shs$72.41 million03/08/2024$1.66$1.62-2.41%$1.74$1.6253,125 shs$72.41 million03/07/2024$1.74$1.66-4.60%$1.76$1.64142,813 shs$74.21 million03/06/2024$1.79$1.74-2.79%$1.84$1.72191,291 shs$77.78 million03/05/2024$1.77$1.79+1.13%$1.82$1.7298,366 shs$80.01 million03/04/2024$1.75$1.77+1.14%$1.90$1.67341,128 shs$79.12 million03/01/2024$1.78$1.75-1.69%$1.88$1.70367,473 shs$78.23 million02/29/2024$1.74$1.78+2.30%$1.92$1.71263,193 shs$79.57 million02/28/2024$1.65$1.74+5.45%$1.76$1.59376,526 shs$77.78 million Related Companies: YS Biopharma Stock Chart Benitec Biopharma Stock Chart IO Biotech Stock Chart Milestone Pharmaceuticals Stock Chart Chimerix Stock Chart Cue Biopharma Stock Chart Anixa Biosciences Stock Chart Annovis Bio Stock Chart Eton Pharmaceuticals Stock Chart Oramed Pharmaceuticals Stock Chart Receive IFRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for InflaRx and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:IFRX) was last updated on 5/29/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaA once-in-a-century investment opportunityStansberry ResearchWrite this ticker symbol down…StocksToTradeYou won't believe what Citigroup just did to it's depositorsAmerican AlternativeWARNING about the death of the U.S. dollar…Colonial MetalsMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InflaRx Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.